Skip to content

Feasibility of Egg White Pudding Supplementation for Individuals in Personal Care Home Centres Needing Dietary Supplementation

Feasibility of Egg White Pudding Supplementation for Individuals in Personal Care Home Centres Needing Dietary Supplementation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07805993
Enrollment
54
Registered
2026-09-08
Start date
2026-06-08
Completion date
2027-02-01
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia in Elderly

Keywords

Protein, Feasibility, Older Adults, Home Care Centres, Sarcopenia, Canada, Manitoba, Protein Pudding, Egg White Pudding, Mini Nutritional Assessment

Brief summary

This trial is an open-label randomized controlled parallel arm feasibility trial. 54 residents in care homes receiving nutrition supplementation (minimum 40% of each sex, ≥ 50 years of age). Participants will receive the egg white pudding (experimental) or a standard currently provided dietary supplement (control) on a daily basis and will be advised to follow any dietary recommendations they receive from their care team. Participants will be recruited at personal care homes throughout Winnipeg. Study visits will take place with a study coordinator at baseline and at 8 weeks (endpoint). Product acceptability will be assessed through dietary logs. This study has been reviewed and approved by The Committee for Harmonized Health Impact, Privacy, and Ethics Review (CHIPER).

Detailed description

This trial is an open-label randomized controlled parallel arm feasibility trial. 54 residents from non-shared health personal care home centres (target of a minimum 40% of each sex, ≥ 50 years of age) will be recruited. Participants will receive the egg white pudding (experimental) 5 days a week or a standard currently provided dietary supplement (control) 7 days a week and will be advised to follow any dietary recommendations they receive from their care team. The personal care home team will approach residents or their ADM to participate in the research. Once a potential participant confirms interest, the research team will approach them for scheduling a screening visit. As part of the screening process, the care team may provide the research team with information on the participant's MDS (Minimum Data Set) level, which is routinely collected by personal care homes in Canada (levels 1-3). This information will be recorded at the screening visit for descriptive purposes only and will not be used to exclude any participants. The research coordinator and research assistant will also oversee and document the dispensing of products, which will be administered by the care team at the home care centre. After the screening visit, study visits will take place with a research coordinator or research assistant at Week 1 (baseline) and at Week 8 (endpoint). Product acceptability will be assessed through feedback questionnaire.

Interventions

DIETARY_SUPPLEMENTEgg White Pudding

Participants will be given a high protein egg white pudding 5 days a week for 8 weeks.

DIETARY_SUPPLEMENTNestle Resource

Participants in the control group will be given 180 ml of Resource 2.0 seven days a week for 8 weeks.

Sponsors

Seven Oaks Hospital Chronic Disease Innovation Centre
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Residing in a partnering Personal Care Home * Participant is willing and able to give informed consent for participation in the trial or has an ADM who is authorized to provide consent on their behalf. * Male or female aged ≥50 years

Exclusion criteria

* Allergy to eggs * Inability to consume treatment product * Unable to provide written consent * Unable to understand English * Does not have an ADM

Design outcomes

Primary

MeasureTime frameDescription
Hand Grip Strength8 weeksHand grip strength will be measured using a specialized handheld device called a hand dynamometer that records the maximum isometric force generated in kilograms or pounds.

Secondary

MeasureTime frameDescription
Waist circumference8 weeksThe study staff will wrap a flexible tape measure around participants' middle at the level of the belly button or just above the hip bones.
Body weight8 weeksBody weight will be measured by participants stepping onto a digital or mechanical weighing scale placed on a hard, flat surface
Calf Circumference8 weeksThe study staff will wrap a flexible tape measure around the widest part of participants' lower leg while keeping the tape snug but comfortable.

Countries

Canada

Contacts

CONTACTNavdeep Tangri, MD, PhD
NTangri@sogh.mb.ca204-631-3834
CONTACTMaryem Zahra, BA
MZahra@sogh.mb.ca204-631-3834

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026